Increasing prescription of drugs for secondary prevention of myocardial infarction. Lipid lowering drugs should be considered too.
作者信息
Taylor A, Reckless J P
出版信息
BMJ. 1996 Jan 27;312(7025):252. doi: 10.1136/bmj.312.7025.252b.
Abstract
摘要
相似文献
1
Increasing prescription of drugs for secondary prevention of myocardial infarction. Lipid lowering drugs should be considered too.增加用于心肌梗死二级预防的药物处方。还应考虑使用降脂药物。
BMJ. 1996 Jan 27;312(7025):252. doi: 10.1136/bmj.312.7025.252b.
2
A case for lipid lowering? Response to Dr Paul Durrington.
Diabet Med. 2001 May;Suppl 3:11-2. doi: 10.1046/j.1464-5491.2001.00001-5.x.
3
Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?老年二级心血管预防中的药物处方率：心血管疾病病史的脆弱性和严重程度有影响吗？
Scand J Prim Health Care. 2015;33(4):260-8. doi: 10.3109/02813432.2015.1117281.
4
Editorial: Lipid-lowering drugs after myocardial infarction.社论：心肌梗死后的降脂药物
Lancet. 1975 Mar 1;1(7905):501-2.
5
Secondary prevention of coronary disease with lipid-lowering drugs.
Lancet. 1989 Mar 4;1(8636):473-4.
6
Lipid-lowering therapy after myocardial infarction: the Bavarian Cholesterol Screening Project.心肌梗死后的降脂治疗：巴伐利亚胆固醇筛查项目
JAMA. 1998 Aug 19;280(7):603-4. doi: 10.1001/jama.280.7.603.
7
Prescribing of lipid regulating drugs and admissions for myocardial infarction in England.英格兰地区调脂药物的处方开具情况及心肌梗死入院情况
BMJ. 2004 Sep 18;329(7467):645. doi: 10.1136/bmj.329.7467.645.
8
Increasing prescription of drugs for secondary prevention of myocardial infarction. Authors' recommendations are too restrictive.用于心肌梗死二级预防的药物处方量在增加。作者的建议过于严格。
BMJ. 1996 Jan 27;312(7025):252. doi: 10.1136/bmj.312.7025.252a.
9
Improving lipid control following myocardial infarction.心肌梗死后改善血脂控制。
Curr Opin Cardiol. 2014 Sep;29(5):454-66. doi: 10.1097/HCO.0000000000000093.
10
Testing the efficacy of lipid-lowering therapy versus revascularization: the time has come, or is it past due?测试降脂治疗与血管重建术的疗效：时机已到，还是早已逾期？
Circulation. 1998 Jun 30;97(25):2584-6. doi: 10.1161/01.cir.97.25.2584.
本文引用的文献
1
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?血清胆固醇浓度降低多少以及多快能降低缺血性心脏病的风险？
BMJ. 1994 Feb 5;308(6925):367-72. doi: 10.1136/bmj.308.6925.367.
2
Increasing prescription of drugs for secondary prevention after myocardial infarction.心肌梗死后二级预防药物处方的增加。
BMJ. 1995 Oct 7;311(7010):917-8. doi: 10.1136/bmj.311.7010.917.
3
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS).在圣托马斯动脉粥样硬化逆转研究（STARS）中，降脂饮食或饮食加胆酸螯合剂对冠状动脉疾病的影响。
Lancet. 1992 Mar 7;339(8793):563-9. doi: 10.1016/0140-6736(92)90863-x.
4
Wrong lesson from Finnish trial of cardiovascular disease prevention.从芬兰心血管疾病预防试验中得出的错误教训。
Lancet. 1992 Feb 22;339(8791):488. doi: 10.1016/0140-6736(92)91089-q.
Zotero 插件